Skip to main content

Table 3 Genomic gains found in more than 10 % of BRCAX breast tumors

From: Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival

Chromosome

CytoBand

Start

Stop

Size bp

Percentage of BRCAX tumors (N = 40)

Candidate oncogenes

Other genes

1

q21.1

143706304

143905470

199,166

15.0

PDE4DIP

SEC22B

q21.1

144219515

144279910

60,395

12.5

RBM8A

GNRHR2, PEX11B, ITGA10, ANKRD35

q21.2

148240535

148367347

126,812

12.5

OTUD7B

VPS45

q21.2

148392365

148504936

112,571

17.5

 

PLEKHO1, APH1A, ANP32E, CA14

q21.2

148519890

148564234

44,344

15.0

 

C1orf54, C1orf51, MRPS21, PRPF3

q32.1

201456918

201966787

509,869

12.5

BTG2

CHIT1, FMOD, ATP2B4

q32.1

202269067

202358437

89,370

12.5

 

C1orf157, SOX13

q32.1

205037481

205260296

222,815

15.0

IL19, IL20, FAIM3

IL24, PIGR, FCAMR, C1orf116

q32.2

205762617

206263053

500,436

12.5

CD46, PLXNA2

CR1, CR1L, CD34

q32.2

207826895

208566054

739,159

12.5

TRAF3IP3,LAMB3

G0S2, HSD11B1, C1orf74, IRF6, C1orf107, SYT14, SERTAD4

q41

213425725

213768607

342,882

12.5

 

KCNK2

q42.12

223406336

224419278

1,012,942

12.5

ENAH, LBR

DNAH14, SRP9, EPHX1, TMEM63A, LEFTY1, PYCR2, LEFTY2, C1orf55, H3F3A, ACBD3

q42.13

225961050

226071970

110,920

12.5

 

JMJD4, SNAP47, MPN2

6

p21.33

31663820

31905687

241,867

12.5

CLIC1, CSNK2B

LST1, NCR3, AIF1, BAT2, BAT3, APOM, BAT4, C6orf47, LY6G5B, LY6G5C, BAT5, LY6G6F, LY6G6E, LY6G6D, LY6G6C, DDAH2, MSH5, C6orf27, VARS, LSM2, HSPA1A, HSPA1B

8

q22.1

98923270

99014727

91,457

12.5

LAPTM4B

MATN2

q22.3

104310836

104453937

143,101

12.5

FZD6, CTHRC1

BAALC

q23.1

107173263

107833235

659,972

12.5

 

OXR1

q24.13

124926272

125341753

415,481

12.5

 

FER1L6

q24.21

130632541

130857683

225,142

12.5

 

GSDMC

12

q13.2

54405492

54500555

95,063

12.5

CIP29

CD63, GDF11, ORMDL2

17

q12

34260921

34473439

212,518

12.5

RPL23, PLXDC1, LASP1

FBXO47

19

q13.33

55918797

56055048

136,251

12.5

KLK15, KLK3

CLEC11A, GPR32, ACPT, C19orf48, KLK1

q13.42

60568830

60853735

284,905

12.5

IL11, UBE2S

TMEM190, RPL28, ZNF579, FIZ1, ZNF524, ZNF580, ZNF581, CCDC106

20

q12

39100100

39358266

258,166

15.0

PLCG1, TOP1

PRO0628, ZHX3

  1. Most frequent gains in BRCAX tumors are highlighted in bold